There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > Putting the Brakes on SARS-CoV-2: Neutralizing Antibodies
  1. Putting the Brakes on SARS-CoV-2: Neutralizing Antibodies

    1. Tuesday, July 28, 2020, 2:30 - 4:00 PM, EST
    2. Webinar
    3. James E. Crowe, Jr., MD, Devin Sok, PhD
    Click the button below to watch the webinar replay
  2. ACROBiosystems is sponsoring this webinar!


    Time: Tuesday, July 28, 2020, 2:30 - 4:00 PM, Eastern Standard Time




    James E. Crowe, Jr., MD
    Director, Vanderbilt Vaccine Center
    Professor, Pediatrics and Pathology, Microbiology and Immunology
    Ann Scott Carrell Chair


    Devin Sok, PhD
    Senior Director, Antibody Discovery and Development

    Event Overview

    SARS-CoV-2 is characterized by its rapid spread and significant human-to-human transmission. With no approved vaccines or treatments yet available, researchers are exploring various medical interventions, including neutralizing monoclonal antibodies (mAbs), to control the global COVID-19 pandemic. The SARS-CoV-2 spike (S) glycoprotein, which promotes entry into host cells, is the main target of neutralizing antibodies. In this multisponsored webinar by The Scientist, a panel of researchers will discuss potential neutralizing antibodies currently under investigation for SARS-CoV-2 treatment.

    Topics to be covered

    · Human monoclonal antibodies for SARS-CoV-2

    · SARS-CoV-2 neutralizing antibodies for global access

New & Hot Products

This web search service is supported by Google Inc.